lymphoblastic


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to lymphoblastic: lymphoblastic lymphoma

lymphoblastic

 [lim″fo-blas´tik]
pertaining to a lymphoblast; producing lymphocytes.

lym·pho·blas·tic

(lim'fō-blas'tik),
Pertaining to the production of lymphocytes.

lym·pho·blas·tic

(lim'fō-blas'tik)
Pertaining to the production of lymphocytes.

lymphoblastic

pertaining to a lymphoblast; producing lymphocytes.
References in periodicals archive ?
This report provides comprehensive information on the therapeutic development for Acute Lymphoblastic Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
To study how this compound would act on acute lymphoblastic leukemia, researchers led by Dr Koramit Suppipat, lead author of the study incubated humanderived leukemic cell lines and primary lymphoblasts from pediatric patients with the compound.
Laura Howe, who lives in Newcastle, was first diagnosed with acute lymphoblastic leukaemia in 1995 when she was seven years old.
Detection of minimal residual disease in lymphoblastic leukemia/lymphoma has similar implications as in acute myeloid leukemia, correlating with a worse prognosis, especially when present at the end of consolidation.
After retrospective analysis of the study cohort we identified only two cases of therapy-related hematological malignancies following conventional chemotherapy for ALL and lymphoblastic NHL during this period.
Lymphoblastic lymphoma accounts for less than three in 100 cases of cancer overall.
CT-guided biopsy of the soft tissue mass in the chest wall showed precursor B lymphoblastic leukemia/lymphoma.
These findings highlight the need for continued careful follow-up of adult survivors of childhood acute lymphoblastic leukemia (ALL), Dr.
Additionally, Fodosine(TM) is currently being studied in a Phase I trial with an oral formulation in cutaneous T-cell lymphoma (CTCL), a Phase II trial in chronic lymphocytic leukemia (CLL) and a Phase I/II trial in B-cell acute lymphoblastic leukemia.
Although the magnitude of this cluster of acute lymphoblastic leukemia (ALL) could be attributed to happenstance, the recent analysis by Steinmaus et al.